Title : Combined radioimmunotherapy and chemotherapy of breast tumors with Y-90-labeled anti-Her2 and anti-CEA antibodies with taxol.

Pub. Date : 2005 Sep-Oct

PMID : 16173788






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 These studies suggest that combined RIT and Taxol therapy are suitable in breast cancers expressing either low amounts of Her2 or CEA, thus expanding the number of eligible patients for combined therapies. Paclitaxel erb-b2 receptor tyrosine kinase 2 Homo sapiens